Main News

02/26/2020

Korea should join efforts in vaccine development to prevent pandemics (JoongAng Ilbo)

by Jerome H. Kim, Director General of the International Vaccine Institute (IVI) Originally published in the JoongAng Ilbo (Korean language) and Korea JoongAng Daily (English language)   Novel Coronavirus SARS-CoV-2 This transmission electron microscope image shows SARS-CoV-2—also known as 2019-nCoV, the virus that causes COVID-19. […]
03/05/2020

International Vaccine Institute and Technical University of Denmark to strengthen external quality assurance in the face of rising antimicrobial resistance in Asia

The Asia Pacific region is vulnerable to the emergence and spread of AMR but there is little high-quality data available on the extent of its impact Quality-assured data is essential for building tailored strategies for preventing the spread of drug-resistant infections IVI is part of […]
03/19/2020

IVI at work on COVID-19

As COVID-19 continues to disrupt communities around the world, IVI remains committed to our mission to protect the world’s most vulnerable people from vaccine-preventable diseases by developing safe, effective, and affordable vaccines for global health. We do this for diseases like cholera and typhoid, as […]
04/16/2020

IVI, INOVIO, and KNIH to partner with CEPI in a Phase I/II clinical trial of INOVIO’s COVID-19 DNA vaccine in South Korea

  The Coalition for Epidemic Preparedness Innovations (CEPI) grants funding $6.9 million to INOVIO and IVI to conduct clinical testing in Korea for INOVIO’s COVID-19 vaccine candidate based on their well-established DNA platform technology Korea National Institute of Health (KNIH) to support IVI’s testing efforts […]